AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RECCE PHARMACEUTICALS LTD

0.365

-0.010-2.67%

Volume:230.82K

Turnover:85.01K

Market Cap:111.51M

PE:-3.22

High:0.375

Open:0.375

Low:0.365

Close:0.375

52wk High:0.730

52wk Low:0.347

Shares:305.52M

Float Shares:168.89M

Volume Ratio:8.70

T/O Rate:0.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.113

EPS(LYR):-0.090

ROE:-1277.62%

ROA:-581.01%

PB:-5.99

PE(LYR):-4.04

Loading ...

Overview Company News Filings

Company Profile

Company Name:

RECCE PHARMACEUTICALS LTD

Exchange:

ASX

Establishment Date:

2007

Employees:

- -

Office Location:

Governor Macquarie Tower,Level 15,1 Farrer Place,Sydney,New South Wales,Australia

Website:

http://www.recce.com.au

Zip Code:

2000

Phone:

Fax:

- -

Introduction:

Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of antibiotics in Australia and the United States. Its lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/RCE.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RCE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RCE.AU\",,,,,undefined,":{"symbol":"RCE.AU","market":"AU","secType":"STK","nameCN":"RECCE PHARMACEUTICALS LTD","latestPrice":0.365,"timestamp":1787292720000,"preClose":0.375,"halted":0,"volume":230817,"delay":0,"changeRate":-0.02666666666666669,"nameEN":"RECCE PHARMACEUTICALS LTD","floatShares":168893037,"shares":305520100,"eps":-0.113284,"marketStatus":"Market Closed","change":-0.01,"latestTime":"08-21 16:12:00 AEST","open":0.375,"high":0.375,"low":0.365,"amount":85010,"amplitude":0.026667,"askPrice":0.38,"askSize":5000,"bidPrice":0.365,"bidSize":30125,"shortable":3,"etf":0,"ttmEps":-0.113284,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.375,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":8.698717926627777,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RCE.AU","preClose":0.385,"auctionPrice":0.385,"auctionVolume":956,"auction":3,"marketStatus":"盘后竞价","timestamp":1787205601261}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RCE.AU\",,,,,undefined,":{"symbol":"RCE.AU","floatShares":168893037,"roa":"-581.01%","roe":"-1277.62%","lyrEps":-0.090423,"volumeRatio":8.698717926627777,"shares":305520100,"dividePrice":0,"high":0.375,"amplitude":0.026667,"preClose":0.375,"low":0.365,"week52Low":0.347,"pbRate":"-5.99","psRate":"114.43","week52High":0.73,"institutionHeld":0,"latestPrice":0.365,"committee":0.715302,"eps":-0.113284,"divideRate":0,"volume":230817,"delay":0,"ttmEps":-0.113284,"open":0.375,"prevYearClose":0.65,"prevWeekClose":0.37,"prevMonthClose":0.37,"prevQuarterClose":0.405,"fiveDayClose":0.37,"twentyDayClose":0.36,"sixtyDayClose":0.56,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RCE.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-04-15","symbol":"RCE.AU","defaultRemindTime":1744675200000,"type":"split","dateTimestamp":1744639200000,"forFactor":990476,"toFactor":1000000,"ratio":0.990476}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RCE.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":310479285,"yearFounded":2007,"address":"Governor Macquarie Tower,Level 15,1 Farrer Place,Sydney,New South Wales,Australia","zipCode":"2000","officePhone":"61 2 9000 1907","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://www.recce.com.au","stockEarnings":[{"period":"1week","weight":-0.0135},{"period":"1month","weight":0.0429},{"period":"3month","weight":-0.2316},{"period":"6month","weight":-0.3652},{"period":"1year","weight":-0.1412},{"period":"ytd","weight":-0.4385}],"compareEarnings":[{"period":"1week","weight":-0.0013},{"period":"1month","weight":0.0219},{"period":"3month","weight":0.0512},{"period":"6month","weight":0.0313},{"period":"1year","weight":0.0865},{"period":"ytd","weight":0.0535}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of antibiotics in Australia and the United States. Its lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.181818,"avgChangeRate":-0.07298},{"month":2,"riseRate":0.090909,"avgChangeRate":-0.057949},{"month":3,"riseRate":0.636364,"avgChangeRate":0.092385},{"month":4,"riseRate":0.454545,"avgChangeRate":0.138551},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.045591},{"month":6,"riseRate":0.454545,"avgChangeRate":0.091277},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.026268},{"month":8,"riseRate":0.4,"avgChangeRate":0.04119},{"month":9,"riseRate":0.2,"avgChangeRate":-0.083267},{"month":10,"riseRate":0.5,"avgChangeRate":0.015341},{"month":11,"riseRate":0.5,"avgChangeRate":0.092476},{"month":12,"riseRate":0.3,"avgChangeRate":0.008161}],"exchange":"ASX","name":"RECCE PHARMACEUTICALS LTD","nameEN":"RECCE PHARMACEUTICALS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RCE.AU\",market:\"AU\",,,undefined,":null}}